Express Pharma

Phenomenex expands chiral screening and separation power with New Lux 3µm Amylose-1 Chiral Columns

2

20160229ep31

Phenomenex, a global leader in the research and manufacture of advanced technologies for the separation sciences, has added a 3µm particle size to the company’s newest chiral selector, Lux Amylose-1, amylose tris (3,5-dimethylphenylcarbamate). These high-efficiency Lux polysaccharide columns are ideal for UHPLC, HPLC and SFC chiral screening and analysis, and now with two sizes – the new 3µm and existing 5µm particles – method scalability from analytical work to preparative purification is seamless.

The affordable Lux Amylose-1 provides valuable enantioselectivity and is a guaranteed alternative to other phases with the same chiral selector. The 3µm-particle media is available in analytical columns while the 5µm-particle media is available in both analytical columns and Phenomenex-patented Axia preparative column hardware, both of which are stable in normal phase, reversed phase, polar organic and SFC conditions.

The Phenomenex Lux amylose and cellulose chiral column line of six chiral selectors comprise an affordable and complementary kit for chiral separations, featuring high efficiency, excellent loading capacity and pressure stability up to 300 bar in a wide range of conditions. Ideal applications for Lux columns include drug enantiomers from the pharmaceutical sector, chiral pesticide analysis in agrochemical settings, flavour analysis and production from the food industry, fragrance isolation and commercialisation in cosmetics and a range of other chiral-chemical raw materials such as intermediates and finished goods.

To complement its comprehensive Lux chiral column line, Phenomenex offers free chiral screening services with greater than 90 per cent success rates from its PhenoLogix application development group, along with over 2,000 chiral applications online that are easily searchable by compound structure or name.

Phenomenex is a global technology leader committed to developing novel analytical chemistry solutions that solve the separation and purification challenges of researchers in industrial, clinical research, government and academic laboratories. From drug discovery and pharma development to food safety and environmental analysis, Phenomenex chromatography solutions accelerate science and help researchers improve global health and well-being.

Contact Details:
Jennifer Dahlgren,
Dahlgren Communications
Phone: (530) 263-6817
Email: [email protected]

Simon Lomas,
Phenomenex, Inc.
Phone: (310) 212-0555 (Extn. 2267)
Email: [email protected]
Website: www.phenomenex.com

Comments are closed.